Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G is a research paper published in The Oncologist (2024). On theSindex it has a DataRank of 0.363. It has been cited 7 times, with 7 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0.0513
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 7 citers.
NCI NIH HHS
Grant: U24 CA196173
NCI NIH HHS
Grant: U10 CA180899
NCI NIH HHS
Grant: U10 CA180886
National Institutes of Health
Grant: 3U24CA196173-09S1
COG Biobanking Support
National Institutes of Health
Grant: 2U10CA180899-06
Children's Oncology Group Statistics and Data Center
National Institutes of Health
Grant: 3U10CA180886-01S1
COG NCTN Network Group Operations Center
National Institutes of Health
Grant: 3P30CA015083-37S2
Mayo Comprehensive Cancer Center Grant
FWCI
1.15
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals